EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 25 / No 3 (Mars 2009) Med Sci (Paris), 25 3 (2009) 259-265 References
Free Access
Issue
Med Sci (Paris)
Volume 25, Number 3, Mars 2009
Page(s) 259 - 265
Section M/S revues
DOI https://doi.org/10.1051/medsci/2009253259
Published online 15 March 2009
  1. Dewhirst FE, Stashenko PP, Mole JE, Tsurumachi T. Purification and partial sequence of human osteoclast-activating factor : identity with interleukin 1 beta. J Immunol 1985; 135 : 2562–8. [Google Scholar]
  2. Miyamoto T, Ohneda O, Arai F, et al. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 2001; 98 : 2544–54. [Google Scholar]
  3. Servet-Delprat C, Arnaud S, Jurdic P, et al. Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia. BMC Immunol 2002; 24 : 3:15. [Google Scholar]
  4. Arron JR, Choi Y. Bone versus immune system. Nature 2000; 408 : 535–6. [Google Scholar]
  5. Pettit AR, Ji H, von Stechow D,et al.TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 2001; 159 : 1689–99. [Google Scholar]
  6. Redlich K, Hayer S, Ricci R,et al. Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest 2002; 110 : 1419–27. [Google Scholar]
  7. Solari F, Jurdic P. Nouveaux concepts sur l’origine des ostéoclastes : relation avec les macrophages normaux et inflammatoires. Med Sci (Paris) 1997; 13 : 1285–93. [Google Scholar]
  8. Rivollier A, Mazzorana M, Tebib J, et al. Immature dendritic cell transdifferentiation into osteoclasts : a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 2004; 104 : 4029–37. [Google Scholar]
  9. Alnaeeli M, Penninger JM, Teng YT. Immune interactions with CD4+ T cells promote the development of functional osteoclasts from murine CD11c+ dendritic cells. J Immunol 2006; 177 : 3314–26. [Google Scholar]
  10. Speziani C, Rivollier A, Gallois A, et al. Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines. Eur J Immunol 2007; 37 : 747–57. [Google Scholar]
  11. Wakkach A, Mansour A, Dacquin R, et al. Bone marrow microenvironment controls the in vivo differentiation of murine dendritic cells into osteoclasts. Blood 2008; 112 : 5074–83. [Google Scholar]
  12. Xing L, Schwarz EM, Boyce BF Osteoclast precursors, RANKL/RANK, and immunology. Immunol Rev 2005; 208 : 19–29. [Google Scholar]
  13. Coury F, Annels N, Rivollier A, et al. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med 2008; 14 : 81–7. [Google Scholar]
  14. Marie P, Halbout P OPG/RANKL : implication et cible thérapeutique dans l’ostéoporose. Med Sci (Paris) 2008; 24 : 105–10. [Google Scholar]
  15. Hsu H, Lacey DL, Dunstan CR, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 1999; 96 : 3540–5. [Google Scholar]
  16. Anderson DM, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997; 390 : 175–9. [Google Scholar]
  17. Kim N, Odgren PR, Kim DK, et al. Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. Proc Natl Acad Sci USA 2000; 97 : 10905–10. [Google Scholar]
  18. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999; 397 : 315–23. [Google Scholar]
  19. Dougall WC, Glaccum M, Charrier K, et al. RANK is essential for osteoclast and lymph node development.Genes Dev 1999; 18 : 2412–24. [Google Scholar]
  20. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin : a novel secreted protein involved in the regulation of bone density. Cell 1997; 89 : 309–19. [Google Scholar]
  21. Yun TJ, Tallquist MD, Aicher A, et al. Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function. J Immunol 2001; 166 : 1482–91. [Google Scholar]
  22. Takayanagi H, Iizuka H, Juji T, et al. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 2000; 43 : 259–69. [Google Scholar]
  23. Crotti TN, Smith MD, Weedon H, et al. Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients : semiquantitative and quantitative analysis. Ann Rheum Dis 2002; 61 : 1047–54. [Google Scholar]
  24. Haynes DR, Barg E, Crotti TN, et al. Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Rheumatology 2003; 42 : 123–34. [Google Scholar]
  25. Paloneva J, Mandelin J, Kiialainen A, et al. DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J Exp Med 2003; 198 : 669–75. [Google Scholar]
  26. Kaifu T, Nakahara J, Inui M, et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest 2003; 111 : 323–32. [Google Scholar]
  27. Nataf S, Anginot A, Vuaillat C, et al. Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. Am J Pathol 2005; 166 : 275–86. [Google Scholar]
  28. Mócsai A, Humphrey MB, Van Ziffle JA,et al. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci USA 2004; 101 : 6158–63. [Google Scholar]
  29. Colonna M, Turnbull I, Klesney-Tait J. The enigmatic function of TREM-2 in osteoclastogenesis. Adv Exp Med Biol 2007; 602 : 97–105. [Google Scholar]
  30. Shinohara M, Koga T, Okamoto K, et al. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell 2008; 132 : 794–806. [Google Scholar]
  31. Lee SH, Kim T, Jeong D, et al. The tec family tyrosine kinase Btk Regulates RANKL-induced osteoclast maturation. J Biol Chem 2008; 283 : 11526–34. [Google Scholar]
  32. Anginot A, Dacquin R, Mazzorana M, Jurdic P. Lymphocytes and the Dap12 adaptor are key regulators of osteoclast activation associated with gonadal failure. PLoS One 2007; 2 : e585. [Google Scholar]
  33. Wu Y, Torchia J, Yao W, et al. Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency. PLoS One 2007; 2 : e586. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.